Vista Pharmaceuticals Ltd Q1 FY2024-2025 Results: Summary

Revenue
₹1.87Cr
Net Profits
₹0.86Cr
Net Profit Margins
-45.99%

Highlights

Revenue:

Vista Pharmaceuticals Ltd’s revenue fell -11.37% since last year same period to ₹1.87Cr in the Q1 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -42.11% fall in its revenue since last 3-months.

Net Profits:

Vista Pharmaceuticals Ltd’s net profit jumped 9.47% since last year same period to ₹0.86Cr in the Q1 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -1055.56% fall in its net profits since last 3-months.

Net Profit Margins:

Vista Pharmaceuticals Ltd’s net profit margin fell -2.14% since last year same period to -45.99% in the Q1 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -1750.51% fall in its net profit margins since last 3-months.

FAQs

The revenue for Vista Pharmaceuticals Ltd in the Q1 results 2024 was ₹1.87Cr.

The net profit for Vista Pharmaceuticals Ltd in the Q1 results 2024 was ₹0.86Cr.

The net profit margin for Vista Pharmaceuticals Ltd in the Q1 results 2024 was -45.99%.

The revenue for Vista Pharmaceuticals Ltd in the Q1 results 2023 was ₹2.11Cr.

The net profit for Vista Pharmaceuticals Ltd in the Q1 results 2023 was ₹0.95Cr.

The net profit margin for Vista Pharmaceuticals Ltd in the Q1 results 2023 was -45.02%.